Evidence map›Paper›PMID 35355747›Full record

ReviewArchives of Razi Institute2021

Consecutive Hits of COVID-19 in India: The Mystery of Plummeting Cases and Current Scenario.

T K Suvvari, C P, S Kuppili, V Kandi, L V S Kutikuppala, V D K Kandula, S Mishra, A K Sarangi, R K Mohapatra, K Dhama

Open access · greenAbstract readReview
In one paragraph

Review in Archives of Razi Institute, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

T K SuvvariNTR University of Health Sciences, Vijayawada, India.
C PRungta College of Dental Sciences and Research, Bhilai, India.
S KuppiliKonaseema Institute of Medical Sciences and Research Foundation, Amalapuram, India.
V KandiDepartment of Microbiology, Prathima Institute of Medical Sciences, Karimnagar, India.
L V S KutikuppalaKonaseema Institute of Medical Sciences and Research Foundation, Amalapuram, India.
V D K KandulaGSL Medical College and General Hospital, Rajahmundry, India.
S MishraBioenergy Lab, School of Biotechnology, KIIT Deemed University, Bhubaneswar, India.
A K SarangiDepartment of Chemistry, School of Applied Sciences, Centurion University of Technology and Management, Odisha, India.
R K MohapatraDepartment of Chemistry, Government College of Engineering, Keonjhar, India.
K DhamaDivision of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, India.
Foundation for Medical Research · INCenturion University of Technology and Management · INDr. NTR University of Health Sciences · INGovernment College of Engineering, KeonjharGSL Medical College & General Hospital · INIndian Veterinary Research Institute · INInstitute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The novel coronavirus disease 2019 (COVID-19)-related pandemic has been in existence for almost 2 years now after its possible emergence from a wet market in the city of Wuhan of the Chinese mainland. Evidence of the emergence and transmission of this virus was attributed to bats and pangolins. The causative virus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has rapidly spread globally, affecting humans considerably with its current death toll to be over 4.7 million out of more than 233 confirmed cases as of September 2021. The virus is constantly mutating and continuously trying to establish itself in humans by increasing its transmissibility and virulence through its numerous emerging variants. Several countries have been facing multiple waves of COVID-19 outbreaks one after the other, putting the medical and healthcare establishments under tremendous stress. Although very few drugs and vaccines have been approved for emergency use, their production capabilities need to meet the needs of a huge global population. Currently, not even a quarter of the world population is vaccinated. The situation in India has worsened during the ongoing second wave with the involvement of virus variants with a rapid and huge surge in COVID-19 cases, where the scarcity of hospital infrastructure, antiviral agents, and oxygen has led to increased deaths. Recently, increased surveillance and monitoring, strengthening of medical facilities, campaigns of awareness programs, progressive vaccination drive, and high collaborative efforts have led to limiting the surge of COVID-19 cases in India to a low level. This review outlines the global status of the pandemic with special reference to the Indian scenario.

Indexed as

COVID-19Disease OutbreaksHumansIndiaSARS-CoV-2ChallengesCOVID-19COVID-appropriate behaviorFears of third wavePandemic scenarioSARS-CoV-2Second wave

Identifiers

PMID35355747
PMCPMC8934068
OpenAlexW3214653778

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.